Loading the map…
Other research and experimental development on natural sciences and engineering · Liverpool
Pharmaserve (North West) Development Company
Pharmaserve (North West) Development Company Limited
Private limited company registered in Liverpool, classed under “Other research and experimental development on natural sciences and engineering”.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
2 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
6 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-30
- AccountsAccounts for a small company made up to 31 December 2025
- AccountsAccounts for a small company made up to 31 December 2024
- DirectorsTermination of appointment of Mark Bromiley as a director on 1 April 2025
- DirectorsTermination of appointment of Mark Bromiley as a secretary on 1 April 2025
- AccountsAccounts for a small company made up to 31 December 2023
- OwnershipCessation of Gerald Francis O'brien as a person with significant control on 19 January 2024
- OwnershipCessation of Brigid Christina Obrien as a person with significant control on 19 January 2024
- OwnershipNotification of Obg Scientific Division Limited as a person with significant control on 19 January 2024
- ChargesSatisfaction of charge 098634200002 in full
- AccountsAccounts for a small company made up to 31 December 2022
- AccountsAccounts for a small company made up to 31 December 2021
- AccountsAccounts for a small company made up to 31 December 2020
17 earlier
- DirectorsAppointment of Mr Mark Bromiley as a secretary on 2 July 2021
- DirectorsAppointment of Mr Mark Bromiley as a director on 2 July 2021
- DirectorsTermination of appointment of Philip Didlick as a secretary on 2 July 2021
- DirectorsDirector's details changed for Mr Padriac Marc O'brien on 5 January 2021
- AccountsAccounts for a small company made up to 31 December 2019
- DirectorsDirector's details changed for Mr, Philip Didlick on 20 November 2019
- DirectorsDirector's details changed for Mr Philip Didlick on 10 October 2019
- AccountsAccounts for a small company made up to 31 December 2018
- AccountsAccounts for a dormant company made up to 31 December 2017
- AccountsAccounts for a dormant company made up to 31 December 2016
- AccountsPrevious accounting period extended from 30 November 2016 to 31 December 2016
- FilingMemorandum and Articles of Association
- FilingResolutions
- ChargesSatisfaction of charge 098634200001 in full
- ChargesRegistration of charge 098634200002, created on 31 January 2017
- ChargesRegistration of charge 098634200001, created on 22 July 2016
- IncorporationIncorporation
- Directors
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Pharmaserve (North West) Development Company do?
Private limited company registered in Liverpool, classed under “Other research and experimental development on natural sciences and engineering”.
›How much turnover does Pharmaserve (North West) Development Company make?
Answered in the full report
›Is Pharmaserve (North West) Development Company profitable?
Pharmaserve (North West) Development Company's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Pharmaserve (North West) Development Company?
Answered in the full report
›Who runs and owns Pharmaserve (North West) Development Company?
Its directors are Philip James Didlick, Gerald Francis O'Brien, Padraic Marc O'Brien. Its owners are shown to subscribers.
›Where is Pharmaserve (North West) Development Company based?
Its registered office is Ayrton Saunders House Parliament Business Park, Commerce Way, Liverpool, L8 7BA, in Liverpool.
›When was Pharmaserve (North West) Development Company founded?
Pharmaserve (North West) Development Company Limited was incorporated on 9 November 2015.
›Is Pharmaserve (North West) Development Company still trading?
The register lists Pharmaserve (North West) Development Company Limited as active.